Effect of surface capping on targeting potential of folate decorated poly (propylene imine) dendrimers

Drug Development and Industrial Pharmacy

Volumn 41, Issue 8, 2015, Pages 1393-1399

  Birdhariya, Babulal ^a   Kesharwani, Prashant ^a   Jain, Narendra Kumar ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Cancer; Cytotoxicity; Dendrimers; Folate; Methotrexate

Indexed keywords

DENDRIMER; FOLIC ACID; METHOTREXATE; POLY(PROPYLENE IMINE); UNCLASSIFIED DRUG; POLY(PROPYLENEIMINE); POLYPROPYLENE;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG RELEASE; EQUILIBRIUM DIALYSIS; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; MICHAEL ADDITION; MTT ASSAY; PROTON NUCLEAR MAGNETIC RESONANCE; SURFACE CAPPING; SURFACE PROPERTY; SUSTAINED DRUG RELEASE; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY; CHEMISTRY; DRUG EFFECTS; HELA CELL LINE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY; PROCEDURES;

DENDRIMERS; DRUG DELIVERY SYSTEMS; FOLIC ACID; HELA CELLS; HEMOLYSIS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MICROSCOPY, ELECTRON, TRANSMISSION; POLYPROPYLENES;

EID: 84938312208     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2014.954584     Document Type: Article

References (27)

1. American Cancer Society. Cancer facts & figures 2014. Atlanta: American Cancer Society; 2014.
2. Kesharwani P, Tekade RK, Jain K, Jain NK. Generation dependent cancer targeting potential of poly(propyleneimine) dendrimer. Biomaterials 2014;35:5539-48.
3. Kesharwani P, Ghanghoria R, Jain NK. Carbon nanotube exploration in cancer cell lines. Drug Discov Today 2012;17:1023-30.
4. Kesharwani P, Tekade RK, Gajbhiye V, et al. Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: A comparison. Nanomed Nanotech Biol Med 2011;7:295-304.
5. Kesharwani P, Jain K, Jain NK. Dendrimer as nanocarrier for drug delivery. Prog Polym Sci 2014;39:268-307.
6. Kesharwani P, Tekade RK, Jain K, Jain NK. Formulation development and in vitro-in vivo assessment of fourth generation PPI dendrimer as cancer targeting vector. Nanomed (Lond) 2014 [Epub ahead of print].
7. Kesharwani P, Gajbhiye V, Tekade RK, Jain NK. Evaluation of dendrimer safety and efficacy through cell line studies. Curr Drug Targets 2011;12:1478-97.
8. Jain K, Kesharwani P, Gupta U, Jain NK. Dendrimer toxicity: Let's meet the challenge. Int J Pharm 2010;394:122-42.
9. Gupta U, Dwivedi SK, Bid HK, et al. Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells. Int J Pharm 2010;393:185-96.
10. Tekade RK, Dutta T, Tyagi A, et al. Surface-engineered dendrimers for dual drug delivery: A receptor up-regulation and enhanced cancer targeting strategy. J Drug Target 2008;16:758-72.
11. Agarwal A, Gupta U, Asthana A, Jain NK. Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent. Biomaterials 2009;30:1-9.
12. Lee RJ, Low PS. Delivery of liposomes into cultured KB cells via folate receptor mediated endocytosis. J Biol Chem 1994;269: 3198-204.
13. Morrison TR, Boyd RN. Organic chemistry. 6th ed. Noida (Uttar Pradesh), India: Dorling Kindrsley Publishers, Prentice Hall of India Pvt. Ltd; 2005.
14. Finar IL. Organic chemistry. 5th ed. Singapore: Pearson Edu. Publishers; 2004.
15. Zhuo RX, Du B, Lu ZR. In-vitro release of 5-fluorouracil with cyclic core dendritic polymer. J Control Release 1999;57: 249-57.
16. Kojima C, Kono K, Maruyama K, Takagishi T. Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. Bioconjug Chem 2000; 11:910-17.
17. Malik N, Wiwattanapatapee R, Klopsch R, et al. Dendrimers: relationship between structure and biocompatibility in vitro and preliminary studies on the biodistribution of 125I-labeled polyamidoamine dendrimers in vivo. J Control Release 2000;65: 133-48.
18. Gajbhiye V, Kumar PV, Tekade RK, Jain NK. PEGylated PPI dendritic architectures for sustained delivery of H2 receptor antagonist. J Med Chem 2009;44:1155-66.
19. Khopade AJ, Caruso F, Tripathi P, et al. Effect of dendrimer on entrapment and release of bioactive from liposomes. Int J Pharm 2002;232:157-62.
20. Asthana A, Chauhan AS, Diwan PV, Jain NK. Poly (amidoamine) (PAMAM) dendritic nanostructures for controlled site specific delivery of acidic anti-inflammatory active ingredient. AAPS PharmSciTech 2005;6:536-42.
21. Dutta T, Agashe HB, Kumar PV, et al. Dendrosome-based gene delivery. J Exp Nano Sci 2006;2:235-48.
22. Kumar PV, Agashe HB, Dutta T, Jain NK. PEGylated dendritic architecture for development of a prolonged drug delivery system for an antitubercular drug. Curr Drug Deliv 2007;4:11-19.
23. Wang DJ, Imae T. Fluorescence emission from dendrimer & its pH dependence. J Am Chem Soc 2004;126:13204-5.
24. Gupta U, Agashe H, Jain NK. Polypropylene imine dendrimer mediated solubility enhancement: Effect of pH and functional groups of hydrophobes. J Pharm Sci 2007;10:358-67.
25. Kesarwani P, Jain K, Tekade RK, et al. Spectrophotometric estimation of Paclitaxel. Int J Adv Pharm Sci 2011;2:29-32.
26. Jain S, Kesharwani P, Tekade RK, Jain NK. One platform comparison of solubilization potential of dendrimer with some solubilizing agents. Drug Dev Ind Pharm 2014 [Epub ahead of print]. doi:10. 3109/03639045. 2014. 900077.
27. Kulhari H, Pooja D, Singh MK, Chauhan AS. Optimization of carboxylate-terminated poly(amidoamine) dendrimer-mediated cisplatin formulation. Drug Dev Ind Pharm 2013 [Epub ahead of print]. doi:10. 3109/03639045. 2013. 858735.